USANA CLO sells shares, receives RSU grant

USANA Health Sciences chief legal officer Joshua Foukas reported two transactions involving company equity.

Accepted by SEC EDGAR 02/23/2026 - 07:12 PM EST Learn about SEC filing dates

Rhea-AI Filing Summary

USANA Health Sciences chief legal officer Joshua Foukas reported two transactions involving company equity. On February 19, 2026, he acquired 36,662 restricted stock units, each representing a right to receive one share of USANA common stock, bringing his RSU holdings to 73,270 units. On February 20, 2026, he executed an open-market sale of 4,461 shares of common stock at an average price of $21.345 per share, after which his directly held common stock position was reported as 0 shares.

Insider Trade Summary

Net Seller: 4,461 shares

Net Sell 2 txns

Insider Foukas Joshua

Role CHIEF LEGAL OFFICER

Sold 4,461 shs ($95K)

Share of Position Sold 100%

Type	Security	Shares	Price	Value
Sale	Common Stock	4,461	$21.345	$95K
Grant/Award	Restricted Stock Units	36,662	$0.00	$0.00

Holdings After Transaction: Restricted Stock Units — 73,270 contracts (Direct); Common Stock — 0 shares (Direct)

Holdings Before and After: Restricted Stock Units, 36,608 to 73,270 contracts (Direct); Common Stock, 4,461 to 0 shares (Direct)

Footnotes (2)

1. F1. Each restricted stock unit represents a contingent right to receive one share of USNA common stock.
2. F2. On February 19th 2026, the reporting person was granted restricted stock units, vesting at 25% on each 19th of February thereafter.

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

What insider transactions did USANA (USNA) report for Joshua Foukas?

USANA reported that chief legal officer Joshua Foukas received 36,662 restricted stock units on February 19, 2026, and executed an open-market sale of 4,461 common shares at $21.345 per share on February 20, 2026.

How many USANA (USNA) restricted stock units does Joshua Foukas now hold?

After the February 19, 2026 grant, Joshua Foukas holds 73,270 restricted stock units. Each unit represents a contingent right to receive one share of USANA common stock, with the award vesting in 25% increments on each February 19 thereafter.

At what price did Joshua Foukas sell USANA (USNA) common stock?

Joshua Foukas sold 4,461 shares of USANA common stock at an average price of $21.345 per share on February 20, 2026. Following this open-market sale, his directly held common stock balance was reported as zero shares.

How do the new USANA (USNA) restricted stock units for Joshua Foukas vest?

The restricted stock units granted to Joshua Foukas on February 19, 2026 vest in 25% tranches on each subsequent February 19. Each vested unit entitles him to receive one share of USANA common stock upon settlement.

What types of securities were involved in the latest USANA (USNA) Form 4?

The Form 4 shows transactions in USANA common stock and restricted stock units. Foukas sold 4,461 common shares in an open-market transaction and was granted 36,662 restricted stock units that convert into shares upon vesting and settlement.

AI-generated analysis. How Rhea-AI works. Not financial advice.

Form 4 Insider Transactions: What Each Field Means →

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

Foukas Joshua

(Last) (First) (Middle)

3838 WEST PARKWAY BLVD.

(Street)

SALT LAKE CITY UT 84120

(City) (State) (Zip)

2. Issuer Name and Ticker or Trading Symbol
USANA HEALTH SCIENCES INC [ USNA ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

	Director		10% Owner
X	Officer (give title below)		Other (specify below)
	CHIEF LEGAL OFFICER

3. Date of Earliest Transaction (Month/Day/Year)
02/19/2026

4. If Amendment, Date of Original Filed (Month/Day/Year)

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Common Stock	02/20/2026		S		4,461	D	$21.345	0	D

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares
Restricted Stock Units	(1)	02/19/2026		A		36,662		(2)	(2)	Common Stock	36,662	$0	73,270	D

Explanation of Responses:

1. Each restricted stock unit represents a contingent right to receive one share of USNA common stock.

2. On February 19th 2026, the reporting person was granted restricted stock units, vesting at 25% on each 19th of February thereafter.

Remarks:

	/s/ Joshua Foukas, Attorney-in-Fact	02/23/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.